ProPharma Welcomes Kevin van Dooren to Strengthen Integrated EU Regulatory and HTA Capabilities
ProPharma is excited to welcome Kevin van Dooren as Vice President, Health Economics and Outcomes Research (HEOR) and Market Access, to our Regulatory Sciences team. The addition of Kevin marks a significant step forward in our commitment to delivering fully integrated regulatory and market access...













